These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2788503)

  • 1. Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.
    Thatcher N; Taylor P; Carroll KB; Loriaux EM; Palmer P; Franks CR
    Cancer Treat Rev; 1989 Jun; 16 Suppl A():161-2. PubMed ID: 2788503
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
    Goey SH; Eggermont AM; Punt CJ; Slingerland R; Gratama JW; Oosterom R; Oskam R; Bolhuis RL; Stoter G
    Br J Cancer; 1995 Nov; 72(5):1283-8. PubMed ID: 7577483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
    Karrison TG; Vogelzang NJ
    Cancer; 1999 Aug; 86(3):546-7. PubMed ID: 10430267
    [No Abstract]   [Full Text] [Related]  

  • 4. 24-hour cyclophosphamide infusion therapy for malignant mesothelioma of the pleura.
    Anderson H; Hasleton P; Michie AB; Johnson RJ; Thatcher N
    Br J Dis Chest; 1988 Jan; 82(1):64-9. PubMed ID: 3166920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
    Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
    Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
    Astoul P; Picat-Joossen D; Viallat JR; Boutin C
    Cancer; 1998 Nov; 83(10):2099-104. PubMed ID: 9827714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage.
    Bjermer L; Grönberg H; Roos G; Henriksson R
    Biotherapy; 1993; 6(1):1-7. PubMed ID: 8507539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma.
    Mulatero CW; Penson RT; Papamichael D; Gower NH; Evans M; Rudd RM
    Lung Cancer; 2001 Jan; 31(1):67-72. PubMed ID: 11162868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
    Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
    Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of mesothelioma with interferon gamma and interleukin 2].
    Boutin C; Viallat JR; Astoul P
    Rev Pneumol Clin; 1990; 46(5):211-5. PubMed ID: 2127468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future?
    Munck C; Mordon SR; Scherpereel A; Porte H; Dhalluin X; Betrouni N
    Ann Thorac Surg; 2015 Jun; 99(6):2237-45. PubMed ID: 25912746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label phase I pilot study of continuous intrapleural infusion of escalated doses of methotrexate in malignant pleural mesothelioma.
    Ellithy MM; El Baghdady NS; El Wakeel LM; Abdeltawab KA; Badary OA
    Am J Clin Oncol; 2013 Oct; 36(5):514-8. PubMed ID: 22781392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative treatment of neoplastic pleural effusions. Talcing of the pleura under pleuroscopy with a mixture of talc and Virgimycin].
    Scarbonchi J; Razzouk H
    Mars Med; 1967; 104(11):939-47. PubMed ID: 4946935
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
    Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
    Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma.
    Omasa M; Hirata T; Shoji T; Bando T; Hasegawa S; Inui K; Wada H
    Thorac Cardiovasc Surg; 2001 Aug; 49(4):233-5. PubMed ID: 11505321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions.
    Viallat JR; Boutin C; Rey F; Astoul P; Farisse P; Brandely M
    Cancer; 1993 Jun; 71(12):4067-71. PubMed ID: 8508372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
    Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
    J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of intravenous Doxil in malignant pleural mesothelioma.
    Oh Y; Perez-Soler R; Fossella FV; Glisson BS; Kurie J; Walsh GL; Truong M; Shin DM
    Invest New Drugs; 2000 Aug; 18(3):243-5. PubMed ID: 10958592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.